Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

100,000 extra GP appointments to be made available in Gloucestershire as part of NHS Long Term Plan

February 4, 2019 Sales and Marketing GP, Gloucestershire, NHS, UK, britain, primare care

GP practices in Gloucestershire are set to offer 100,000 more appointments for patients in the coming year. The initiative comes …
News

FDA knocks back Alkermes’ opioid-based depression therapy over lack of evidence

February 4, 2019 Sales and Marketing Alkermes, FDA, major depressive disorder, pharma, rejection

Alkermes experimental opioid-based depression therapy ALKS 5461 has been rejected by the FDA, it has emerged, in the adjunctive treatment …
News

Cambridgeshire and Peterborough NHS Foundation Trust launches mental health clinical trials

February 4, 2019 Sales and Marketing UK, clinical trials, clozapine, mental health, schizophrenia

The Cambridgeshire and Peterborough NHS Foundation Trust’s Windsor Research Unit is offering patients the chance to participate in clinical trials …
News

Obesity-related cancers on the rise amongst millennials

February 4, 2019 Sales and Marketing Cancer, obesity, oncology, young people

Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …
News

Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx

February 1, 2019 Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma

In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …
News

Top Ten most popular articles on Pharmafile.com this week!

February 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
News

Novartis’ CAR-T therapy Kymriah gets NICE green light in diffuse large B-cell lymphoma

February 1, 2019 Medical Communications, Sales and Marketing CAR-T, Cancer, Kymriah, NICE, Novartis, lymphoma, pharma

NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …
News

Repurposed drugs: The Supreme Court deals a blow to patentees

January 31, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Feature

Mylan’s Wixela becomes first FDA-approved generic version of GSK’s Advair inhaler

January 31, 2019 Sales and Marketing Advair, COPD, FDA, Wixela, asthma, generic, pharma

Mylan’s Wixela has become the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler to …
News

Richard Ridinger resigns from CEO position at Lonza causing shares to plummet

January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland

Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
Appointment

Read Pharmafocus January/February 2019 edition online now!

January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines

We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …
News

Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia

January 29, 2019 Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma

It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …
News

Alexander Hardy returns to Genentech as new CEO

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
News

Philip Hampton to step down from chairman role at GSK

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
Appointment

Novartis warns of huge impact of no-deal Brexit

January 28, 2019 Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma

Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026